New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
Heart failure affects an estimated 64.3 million people worldwide
Adverse events were similar to placebo, and no AP-101-induced antibody responses were detected
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
Capricor’s BLA for Deramiocel received Priority Review in March 2025
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
The stable raw materials prices, focused cost improvement initiatives and intensified customer acquisitions helped the company to improve its margin profile
Subscribe To Our Newsletter & Stay Updated
